ARTICLE | Company News
Beactica, Almac deal
December 12, 2011 8:00 AM UTC
Beactica will use its Sprint surface plasmon resonance (SPR) drug discovery technology to identify high-quality fragment hits against undisclosed cancer targets from Almac's Almac Discovery Ltd. unit....